A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.
Gupta A, Nuber N, Esslinger C, Wittenbrink M, Treder M, Landshammer A, Noguchi T, Kelly M, Gnjatic S, Ritter E, von Boehmer L, Nishikawa H, Shiku H, Old L, Ritter G, Knuth A, van den Broek M.
Gupta A, et al. Among authors: von boehmer l.
Cancer Immun. 2013;13:3. Epub 2013 Jan 15.
Cancer Immun. 2013.
PMID: 23390374
Free PMC article.